Avelo Therapeutics is a startup based in Germany, most recent round Seed, 1 tracked investor.
Avelo Therapeutics is a company founded in 2017 headquartered in Germany. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Avelo Therapeutics is a biotech company developing novel small molecule therapeutics for cancer treatment. Their lead program targets a novel mechanism in the DNA damage response pathway to overcome resistance to current therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.